Louisiana State Employees Retirement System Acquires Shares of 6,200 The Clorox Company $CLX

Louisiana State Employees Retirement System bought a new position in shares of The Clorox Company (NYSE:CLXFree Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,200 shares of the company’s stock, valued at approximately $643,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wilkins Investment Counsel Inc. grew its stake in Clorox by 250.6% during the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares in the last quarter. Morningstar Investment Management LLC raised its position in shares of Clorox by 131.8% in the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares in the last quarter. Swiss Life Asset Management Ltd boosted its stake in shares of Clorox by 221.4% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after buying an additional 59,533 shares during the last quarter. National Pension Service grew its position in shares of Clorox by 68.9% during the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock worth $2,777,000 after buying an additional 11,233 shares in the last quarter. Finally, Birch Hill Investment Advisors LLC acquired a new stake in shares of Clorox during the fourth quarter worth approximately $22,103,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Up 0.2%

Clorox stock opened at $97.45 on Wednesday. The firm’s 50-day moving average is $94.19 and its 200-day moving average is $104.20. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company has a market cap of $11.78 billion, a P/E ratio of 15.82, a PEG ratio of 0.46 and a beta of 0.54.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the prior year, the business earned $1.45 earnings per share. Clorox’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CLX. Jefferies Financial Group cut their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 price objective on shares of Clorox in a report on Friday, May 1st. BNP Paribas Exane dropped their target price on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research report on Tuesday, May 12th. Barclays reduced their price target on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. Finally, TD Cowen lifted their price target on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $103.40.

Get Our Latest Analysis on CLX

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is currently owned by insiders.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.